This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density
Journal of Experimental & Clinical Cancer Research Open Access 14 November 2023
-
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Signal Transduction and Targeted Therapy Open Access 17 December 2019
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Marra, G. & Boland, C.R. J. Natl Cancer Inst. 87, 1114–1125 (1995).
Thibodeau, S.N., Bren, G. & Schaid, D.J. Science 260, 816– 819 (1993).
Aaltonen, L.A. et al. Science 260, 812–816 (1993).
Ionov, Y., Peinado, M.A., Malkhosyan, S., Shibata, D. & Perucho, M. Nature 363, 558–561 (1993).
Modrich, P. & Lahue, R. Annu. Rev. Biochem. 65 , 101–133 (1996).
Bellacosa, A. et al. Proc. Natl Acad. Sci. USA 96, 3969– 3974 (1999).
Malkhosyan, S., Rampino, N., Yamamoto, H. & Perucho, M. Nature 382, 499–500 ( 1996).
Calin, G., Herlea, V., Barbanti-Brodano, G. & Negrini, M. Cancer Res. 58, 3777–3781 (1998).
Deloukas, P. et al. Science 282, 744–746 (1998).
Collins, A., Frezal, J., Teague, J. & Morton, N.E. Proc. Natl Acad. Sci. USA 93, 14771–14775 (1996).
Boland, C.R. et al. Cancer Res. 58, 5248– 5257 (1998).
Dietmaier, W. et al. Cancer Res. 57, 4749– 4756 (1997).
Acknowledgements
We thank P. Tsichlis and A. Knudson for advice and encouragement; P. Engstrom for support; S. Litwin for statistical analysis; L. Cicchillitti for technical assistance; A. Tosolini for assistance with FISH mapping; and W. Kruger for critical reading of the manuscript. This work was supported by American Cancer Society grant IRG-191, Public Health Service grants CA78412 and CA70328, the Aaron Gold Cancer Prevention Research Fund, the McGorty Foundation, the Millie and Julius Roden Memorial Research Fund, the Italian Association for Cancer Research Special Project 'Hereditary Colorectal Tumors' and Italian National Research Council contract no. 97.04207.CT04. Additional support was provided by Public Health Service grant CA-06927 and by an appropriation from the Commonwealth of Pennsylvania to the Fox Chase Cancer Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Riccio, A., Aaltonen, L., Godwin, A. et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nat Genet 23, 266–268 (1999). https://doi.org/10.1038/15443
Issue Date:
DOI: https://doi.org/10.1038/15443
This article is cited by
-
MBD4 loss results in global reactivation of promoters and retroelements with low methylated CpG density
Journal of Experimental & Clinical Cancer Research (2023)
-
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Signal Transduction and Targeted Therapy (2019)
-
MBD4 gene is associated with rheumatoid arthritis in Chinese patients in Taiwan
Rheumatology International (2012)
-
Microsatellite Instability Is Associated With a Better Prognosis for Gastric Cancer Patients After Curative Surgery
World Journal of Surgery (2012)